GALT Faces Big Test Today, ABBV Clears Psoriasis Trial, DEPO Cuts 40% Of Staff

Today's Daily Dose brings you news about an important announcement to be made by Galectin; Ironwood Pharma's phase II study results of IW-1973 in patients with type 2 diabetes and hypertension; Depomed's NUCYNTA deal and restructuring; Heron's public offering; AbbVie's psoriasis study results and Zogenix's Dravet syndrome trial results.

from RTT - Biotech http://ift.tt/2ARBPOL
via IFTTT